Chile · Delayed Price · Currency is CLP Empresas CMPC Earnings Call Transcripts
Fiscal Year 2025
-
Fourth quarter 2025 saw higher sales and net income, with pulp driving growth and Softys maintaining margins despite tough competition. Biopackaging struggled with weak demand, while strategic asset sales and port investments support future projects.
-
Q3 2025 saw $1.9B in sales, $260M EBITDA, and $34M net income, with declines driven by lower pulp prices and the absence of non-core asset sales. Hybrid bonds and asset monetization are supporting liquidity, while margin recovery and pulp price increases are expected.
-
Q2 2025 saw sales of $1.9B, EBITDA of $332M, and net income of $81M, with sequential EBITDA growth but year-over-year declines due to lower prices. Major restructuring, a $74M non-recurring gain, and continued deleveraging efforts were key highlights.
-
First quarter 2025 saw $1.8B in sales, $278M EBITDA, and $50M net income, with Pulp leading segment results. Softis and biopackaging faced margin and demand pressures, but cost efficiencies and asset sales supported cash flow and deleveraging.
Fiscal Year 2024
-
Q4 2024 saw a 3% drop in sales and a sharp decline in net income, mainly due to lower pulp prices and currency headwinds. Pulp volumes rose, but Softys and Biopackaging margins were pressured. Net debt/EBITDA improved to 3.15x, and CapEx increased for maintenance.
-
3Q 2024 saw strong EBITDA and net income growth, led by the Pulp segment, while Softys faced headwinds from FX and lower demand. Net debt to EBITDA improved, and significant projects and acquisitions were highlighted. Overcapacity and market volatility remain key risks.
-
The company is advancing a 2030 strategy centered on sustainability, innovation, and cost leadership, with major investments like the $4.5 billion Natureza pulp project and a focus on Softys’ growth in Latin America. Financial discipline, digital transformation, and ambitious ESG goals underpin long-term value creation.
-
Second quarter 2024 saw $1.888 billion in sales, $377 million EBITDA, and $125 million net income, with improved cost control and a focus on profitability. Pulp margins rose on higher prices and lower costs, while Softys and Biopackaging faced margin pressure from competition and currency effects.